Subtopic Deep Dive

Aconitum Alkaloids Anticancer Effects
Research Guide

What is Aconitum Alkaloids Anticancer Effects?

Aconitum alkaloids anticancer effects investigate the cytotoxicity of compounds like aconitine from Aconitum plants against cancer cell lines through apoptosis induction and microtubule disruption.

Research focuses on in vitro and xenograft studies evaluating aconitine and derivatives for therapeutic potential. Key papers include Wada et al. (2010) on structure-activity relationships against A549 lung carcinoma cells (35 citations) and Gao et al. (2017) on aconitine-induced apoptosis in H9c2 cells via mitochondria-mediated pathways (57 citations). Over 10 papers from provided lists address related toxicity and bioactivity.

Curated Papers

Key Challenges

Why It Matters

Aconitum alkaloids offer leads for novel chemotherapeutics due to unique mechanisms like microtubule disruption in A549 cells (Wada et al., 2010). They address gaps in chemotherapy-induced neuropathy treatments (Schröder et al., 2013). Toxicity mitigation strategies, such as nanoparticle encapsulation, enhance safety for clinical translation (Ke et al., 2015). These compounds from traditional Chinese medicine support drug discovery in oncology (Shaw, 2010).

Key Research Challenges

High Cardiotoxicity

Aconitine induces cardiomyocyte damage via mitophagy inhibition and TNFα-NLRP3 signaling (Fu et al., 2019). Apoptosis in cardiac H9c2 cells occurs through mitochondrial pathways (Gao et al., 2017). Balancing anticancer effects against heart risks limits therapeutic use (Yang et al., 2018).

Toxicity Detoxification

Processing Aconitum roots reduces diester-diterpenoid alkaloid toxicity but requires optimization (Chan et al., 2021). Sweroside alleviates aconitine cardiotoxicity in H9c2 cells (Ma et al., 2018). Nanoparticle encapsulation lowers in vivo toxicity (Ke et al., 2015).

Structure-Activity Optimization

Semi-synthetic C20-diterpenoid derivatives show varying cytotoxicity against A549 cells (Wada et al., 2010). Diterpenoid alkaloid classification reveals bioactivity patterns (Thawabteh et al., 2021). Predicting anticancer potency from chemical modifications remains challenging.

Essential Papers

Toxicological Risks of Chinese Herbs

Deborah Shaw · 2010 · Planta Medica · 186 citations

As traditional Chinese medicine (TCM) has become more popular there have been increasing concerns about safety and potential toxicity of the Chinese materia medica (CMM) comprising plants, animal p...

Relationships between the Toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the Toxicokinetics of Its Main Diester-Diterpenoid Alkaloids

Mengbi Yang, Xiaoyu Ji, Zhong Zuo · 2018 · Toxins · 81 citations

The processed lateral root of Aconitum carmichaelii Deb (Aconiti Radix lateralis praeparata or Fuzi) is a potent traditional herbal medicine extensively used in treatment of cardiovascular diseases...

Can Medical Herbs Stimulate Regeneration or Neuroprotection and Treat Neuropathic Pain in Chemotherapy-Induced Peripheral Neuropathy?

Sven Schröder, Kathrin Beckmann, Giovanna Franconi et al. · 2013 · Evidence-based Complementary and Alternative Medicine · 74 citations

Chemotherapy-induced neuropathy (CIPN) has a relevant impact on the quality of life of cancer patients. There are no curative conventional treatments, so further options have to be investigated. We...

The toxicology and detoxification of Aconitum: traditional and modern views

Yau-Tuen Chan, Ning Wang, Yibin Feng · 2021 · Chinese Medicine · 73 citations

Abstract Aconitum carmichaeli Debx.- derived herbal medicine has been used for anti-inflammation and anti-arrhythmia purpose for more than two thousand years. It is processed into Chuanwu ( Radix A...

Aconitine induces cardiomyocyte damage by mitigating BNIP3‐dependent mitophagy and the TNFα‐NLRP3 signalling axis

Peng Fu, Nan Zhang, Chunting Wang et al. · 2019 · Cell Proliferation · 68 citations

Abstract Objectives Aconitine, the natural product extracted from Aconitum species, is widely used for the treatment of various diseases, including rheumatism, arthritis, bruises, fractures and pai...

Sweroside Alleviated Aconitine-Induced Cardiac Toxicity in H9c2 Cardiomyoblast Cell Line

Liqun Ma, Yu You, Hui Chen et al. · 2018 · Frontiers in Pharmacology · 63 citations

Aconitine is the main bioactive ingredient of Aconitum plants, which are well-known botanical herbs in China. Aconitine is also notorious for its high cardiotoxicity, as it can induce life-threaten...

Classification, Toxicity and Bioactivity of Natural Diterpenoid Alkaloids

Amin Mahmood Thawabteh, Alà Thawabteh, Filomena Lelario et al. · 2021 · Molecules · 60 citations

Diterpenoid alkaloids are natural compounds having complex structural features with many stereo-centres originating from the amination of natural tetracyclic diterpenes and produced primarily from ...

Reading Guide

Foundational Papers

Start with Shaw (2010) for toxicity risks in Chinese herbs, then Wada et al. (2010) for structure-activity against A549 cells to establish baseline mechanisms and safety concerns.

Recent Advances

Study Fu et al. (2019) on aconitine mitophagy in cardiomyocytes and Thawabteh et al. (2021) on diterpenoid alkaloid classification for updated bioactivity insights.

Core Methods

Cytotoxicity assays (MTT/IC50 on A549/H9c2); apoptosis detection (flow cytometry, TUNEL); mitochondrial pathway analysis (Western blot BNIP3/TNFα); nanoparticle encapsulation for detox (Ke et al., 2015).

How PapersFlow Helps You Research Aconitum Alkaloids Anticancer Effects

Discover & Search

Research Agent uses searchPapers and exaSearch to find Aconitum alkaloid papers, then citationGraph on Wada et al. (2010) reveals 35 related works on cytotoxicity against A549 cells. findSimilarPapers expands to aconitine apoptosis studies like Gao et al. (2017).

Analyze & Verify

Analysis Agent applies readPaperContent to extract mechanisms from Fu et al. (2019), verifies claims with CoVe against Shaw (2010) toxicity data, and runs PythonAnalysis for dose-response curves from Ma et al. (2018) using pandas for IC50 stats. GRADE grading scores evidence strength for cardiotoxicity claims.

Synthesize & Write

Synthesis Agent detects gaps in toxicity mitigation post-Wada et al. (2010), flags contradictions between anticancer effects (Gao et al., 2017) and cardiac risks (Fu et al., 2019). Writing Agent uses latexEditText, latexSyncCitations for Shaw (2010), and latexCompile for reports; exportMermaid diagrams signaling pathways.

Use Cases

"Extract dose-response data from aconitine cardiotoxicity papers and plot IC50 curves"

Research Agent → searchPapers('aconitine H9c2 IC50') → Analysis Agent → readPaperContent(Gao et al. 2017) → runPythonAnalysis(pandas plot IC50 from extracted data) → matplotlib graph of toxicity thresholds.

"Write LaTeX review on Aconitum alkaloids structure-activity vs A549 cells"

Synthesis Agent → gap detection(Wada et al. 2010) → Writing Agent → latexEditText(structure-activity section) → latexSyncCitations(Thawabteh et al. 2021) → latexCompile → PDF with cited derivatives table.

"Find GitHub code for Aconitum alkaloid molecular docking simulations"

Research Agent → searchPapers('Aconitum docking') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for aconitine-cancer protein docking.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(50+ Aconitum papers) → citationGraph(Shaw 2010 hub) → structured report on anticancer vs toxicity. DeepScan analyzes 7 steps: readPaperContent(Fu et al. 2019) → CoVe verification → GRADE scoring. Theorizer generates hypotheses on nanoparticle detox (Ke et al. 2015) combined with apoptosis induction.

Try Doxa for Aconitum Alkaloids Anticancer Effects Research

Frequently Asked Questions

What defines Aconitum alkaloids anticancer effects?

Cytotoxicity of aconitine and derivatives against cancer cells like A549 via apoptosis and microtubule disruption, as in Wada et al. (2010).

What methods study these effects?

In vitro assays on H9c2/A549 cells measure apoptosis (Gao et al., 2017); xenograft models evaluate in vivo potency; structure-activity via semi-synthetic derivatives (Wada et al., 2010).

What are key papers?

Foundational: Shaw (2010, 186 citations) on risks; Wada et al. (2010, 35 citations) on A549 cytotoxicity. Recent: Fu et al. (2019, 68 citations) on mitophagy; Thawabteh et al. (2021, 60 citations) on bioactivity.

What open problems exist?

Reducing cardiotoxicity while preserving anticancer activity (Fu et al., 2019; Yang et al., 2018); optimizing derivatives for clinical trials (Wada et al., 2010).